1. Home
  2. AUPH vs NN Comparison

AUPH vs NN Comparison

Compare AUPH & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • NN
  • Stock Information
  • Founded
  • AUPH 1993
  • NN 2007
  • Country
  • AUPH Canada
  • NN United States
  • Employees
  • AUPH N/A
  • NN N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • NN Industrial Machinery/Components
  • Sector
  • AUPH Health Care
  • NN Industrials
  • Exchange
  • AUPH Nasdaq
  • NN Nasdaq
  • Market Cap
  • AUPH 1.1B
  • NN 1.8B
  • IPO Year
  • AUPH 1999
  • NN N/A
  • Fundamental
  • Price
  • AUPH $9.04
  • NN $16.15
  • Analyst Decision
  • AUPH Strong Buy
  • NN
  • Analyst Count
  • AUPH 2
  • NN 0
  • Target Price
  • AUPH $11.50
  • NN N/A
  • AVG Volume (30 Days)
  • AUPH 2.0M
  • NN 1.5M
  • Earning Date
  • AUPH 07-31-2025
  • NN 08-06-2025
  • Dividend Yield
  • AUPH N/A
  • NN N/A
  • EPS Growth
  • AUPH N/A
  • NN N/A
  • EPS
  • AUPH 0.27
  • NN N/A
  • Revenue
  • AUPH $247,295,000.00
  • NN $6,162,000.00
  • Revenue This Year
  • AUPH $12.15
  • NN $18.26
  • Revenue Next Year
  • AUPH $18.34
  • NN $4.59
  • P/E Ratio
  • AUPH $34.04
  • NN N/A
  • Revenue Growth
  • AUPH 29.20
  • NN 51.10
  • 52 Week Low
  • AUPH $5.20
  • NN $6.47
  • 52 Week High
  • AUPH $10.67
  • NN $18.54
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 64.76
  • NN 72.74
  • Support Level
  • AUPH $7.36
  • NN $15.84
  • Resistance Level
  • AUPH $9.10
  • NN $16.58
  • Average True Range (ATR)
  • AUPH 0.45
  • NN 0.71
  • MACD
  • AUPH 0.12
  • NN 0.07
  • Stochastic Oscillator
  • AUPH 96.69
  • NN 82.88

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About NN NextNav Inc.

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.

Share on Social Networks: